drugset / Trial / NCT03489512

Comparison Trial for Chloraprep Versus Aqueous Chlorhexidine (2%) for the Prevention of Catheter-related Bacteremia

NCT03489512

Non-randomizedParallel-groupOpen-labelPrevention

Summary

A multicentre, open-label clinical trial of two groups comparing cutaneous asepsis with chlorhexidine gluconate at 2% + isopropyl alcohol 70% in relation to the placement of central venous catheters (Study group) with standard asepsis with aqueous chlorhexidine at 2% (Group Control). The incidence of catheter related bacteremia, the incidence of colonization of the skin and the incidence of colonization of the central venous catheter will be evaluated.

Timeline

Start
2019-10-01
Primary completion
2020-10-01
Completion
2021-04-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Chlorhexidine Small molecule 2 % Topical
Subject Isopropyl alcohol Other / unclassified 70 % Topical